| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/08037051.2014.972816 |
| P698 | PubMed publication ID | 25390761 |
| P50 | author | Şevket Balta | Q40140830 |
| P2093 | author name string | Murat Karaman | |
| Turgay Celık | |||
| Mustafa Dınc | |||
| A Tas | |||
| Atıla Iyısoy | |||
| Cengız Ozturk | |||
| Fosca Quartı-Trevano | |||
| Francesco Fıcı | |||
| Guıdo Grassı | |||
| Gulcan Kurt | |||
| Hılmı U Unal | |||
| M Ilker Yılmaz | |||
| Saıt Demırkol | |||
| Selım Kılıc | |||
| Seyıt Ahmet Ay | |||
| P433 | issue | 1 | |
| P921 | main subject | essential hypertension | Q988405 |
| P304 | page(s) | 55-60 | |
| P577 | publication date | 2014-11-12 | |
| P1433 | published in | Blood Pressure | Q15754419 |
| P1476 | title | Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan | |
| P478 | volume | 24 |
| Q89992925 | Amlodipine alters hemorheological parameters: Increased efficacy at the cost of edema? |
| Q47557757 | Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment |
| Q92723266 | Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea |
| Q92130367 | Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation |
| Q90595637 | Endocan Concentration in Kidney Transplant Recipients |
| Q91909081 | Endocan and Erectile Dysfunction |
| Q38797262 | Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension |
| Q89687386 | Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes |
| Q61796690 | Endocan as a marker of microvascular inflammation in kidney transplant recipients |
| Q38968206 | Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study. |
| Q48162254 | Endocan: a new biomarker associated with inflammation in type 2 diabetes mellitus? |
| Q49404504 | Evaluation of changes in left ventricular structure and function in hypertensive patients with coronary artery disease after PCI using real-time three-dimensional echocardiography |
| Q39028024 | Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation |
| Q28087302 | Immunity in arterial hypertension: associations or causalities? |
| Q91721088 | Long Noncoding RNA HOXA-AS3 Integrates NF-κB Signaling To Regulate Endothelium Inflammation |
| Q37260183 | Plasma endocan level and prognosis of immunoglobulin A nephropathy |
| Q37548133 | Serum Endocan Levels Associated with Hypertension and Loss of Renal Function in Pediatric Patients after Two Years from Renal Transplant |
| Q39738902 | Serum Endocan Levels in Children with Febrile Neutropenia |
| Q38876082 | Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients. |
| Q36314793 | Serum endocan levels in women with restless legs syndrome |
| Q60961723 | The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis |
| Q26774561 | Vascular endothelial dysfunction and pharmacological treatment |
Search more.